Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Baumgartner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 19, 2020
An example of how to establish the thermodynamic stability relationship between two polymorphs of a compound highly prone to solvate formationNorbert Nagel, Bruno Baumgartner, Harald Berchtold
Journal of Pharmaceutical Sciences|September 2, 2003
Indexing powder patterns in physical form screening: instrumentation and data qualityAlastair J Florence, Bruno Baumgartner, Chris Weston, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 1, 2013
An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approachChristine Petzoldt, Oliver Bley, Stephen J Byard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2012
From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitorMartin Philipp Feth, Winfried Heyse, Bruno Baumgartner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 16, 2010
Challenges in the development of hydrate phases as active pharmaceutical ingredients--an exampleMartin P Feth, Norbert Nagel, Bruno Baumgartner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 19, 2020
An example of how to establish the thermodynamic stability relationship between two polymorphs of a compound highly prone to solvate formationNorbert Nagel, Bruno Baumgartner, Harald Berchtold
Journal of Pharmaceutical Sciences|September 2, 2003
Indexing powder patterns in physical form screening: instrumentation and data qualityAlastair J Florence, Bruno Baumgartner, Chris Weston, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 1, 2013
An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approachChristine Petzoldt, Oliver Bley, Stephen J Byard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2012
From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitorMartin Philipp Feth, Winfried Heyse, Bruno Baumgartner, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 16, 2010
Challenges in the development of hydrate phases as active pharmaceutical ingredients--an exampleMartin P Feth, Norbert Nagel, Bruno Baumgartner, et al.
Pageof 1